The trajectory of the erectile dysfunction drug presents a challenging picture for shareholders. While the initial release generated massive gains, the lapse of its patent opened the avenue to generic versions, https://royzhyf119224.educationalimpactblog.com/63384374/viagra-and-pharma-a-volatile-opportunity